Citations

Showing 10 of 108094 citations.

From Collaborative Care to Population-based Management for Depression in Primary Care: Development of Clinical Databases and Applications for Quality Improvement and Research
Savitz, Samuel T. , Kurtzhals, Aaron A., Drews, Maureen S., Breitinger, Scott , Sawchuk, Craig N. , Leasure, William B. , Brennan, RoxAnne, Lebow, Jocelyn , Angstsman, Kurt B, Williams, Mark D. , Lebow, Jocelyn

Mayo Clinic

No container title available | September 22, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1739841/v1 Get It

Abstract Background: To describe the process of developing an evolving database for Mayo Clinic primary care patients who screen positive for depression. The databases will support a broad use of these data for current and future quality improvement and research efforts. The description of their development will serve as an example for other institutions attempting to create similar data resources. Methods: The adult database (patients aged ³ 18) has data from 2007 and the adolescent database (patients aged 12 to < 18) from 2011. To be included, a patient had to be eligible for collaborative care model as a primary care patient with at least moderate symptoms of unipolar depression. The patient did not have to be enrolled in collaborative care model. The main domains of measurement are demographics, social determinants of health, mental health and substance abuse conditions, other comorbidities, interaction with collaborative care model, and questionnaire results. The data is being continuously updated as new data becomes available. Results: The adult database currently includes 117,619 unique patients with a mean age of 44.7 years, and is 66.4% female, and 88.1% non-Hispanic white. The adolescent database includes 14,684 unique patients with a mean age of 14.8 years, is 66.7% female, and 79.7% non-Hispanic white. Conclusions: These large, longitudinal, and evolving databases are a key step towards developing a learning environment to improve quality of care and conduct population-based research for patients with depression in primary care settings.
To predict the left ventricular endocardial Scar tissue pattern using Radon descriptor-based machine learning
Singh, Yashbir , Deepa, Deepa, Singh, Yashbir , Mansoor, Wathiq , Atalla, Shadi , Paul, Rahul

Mayo Clinic

No container title available | September 22, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2073569/v1 Get It

Abstract Objective: Scar tissue is an identified cause for the development of malignant ventricular arrhythmias in patients of myocardial infarction, which ultimately leads to cardiac death, a fatal outcome. We aim to evaluate the left ventricular endocardial Scar tissue pattern using Radon descriptor-based machine learning. We performed automated LV segmentation to find the LV endocardial wall, performed morphological operations, and marked the region of the scar tissue on the endocardial wall of LV. Motivated by a Radon descriptor-based machine learning approach; the patches of 17 patients from CT images of the heart were used and categorized into “endocardial Scar tissue” and “normal tissue” groups. The ten feature vectors are extracted from patches using Radon descriptors and fed into a traditional machine learning model. Results: The decision tree has shown the best performance with 98.07% accuracy. This study is the first attempt to provide a Radon transform-based machine learning method to distinguish patterns between “endocardial Scar tissue” and “normal tissue” groups. Our proposed research method could be potentially used in advanced interventions.
Impact of Glomerulitis on Long-term Outcomes After Kidney Transplantation
Whigham, Morgan, Heilman, Raymond L. , Nair, S. , Lim, Elisabeth S. , Jaramillo, Andrés , Ramón, Daniel S. , Ryan, Margaret , Nair, Sumi Sukumaran, Ryan, Margaret S, Mour, Girish K., Jaramillo, Andres , Buras, Matthew , Mour, Girish

Mayo Clinic

Transplantation Direct | September 22, 2022 | Volume: 8 | Issue: 10 | Pages: e1381

10.1097/txd.0000000000001381 | PMID 36204188 Get It

Background. The Banff classification scheme provides a framework for interpreting transplant kidney biopsies and has undergone various updates in the past 2 decades especially related to antibody-mediated rejection. The clinical significance of early glomerulitis seen within 4 mo on protocol biopsies has received limited attention. We hypothesized that early glomerulitis seen on protocol biopsies will lead to significant adverse outcomes as assessed by histopathology and allograft outcome. Methods. A single-center retrospective study of a cohort of patients who underwent protocol biopsies within 4 mo after transplantation with timely follow-up protocol biopsies were assessed. Patients with recurrent glomerulonephritis were excluded. Results. We calculated glomerulitis (g) scores for 2212 biopsy specimens and identified 186 patients with glomerulitis (g > 0) and 2026 patients without glomerulitis (g = 0). The progression to chronic transplant glomerulopathy at 1 and 2 y was higher in patients with g > 0 as compared with g = 0 (year 1, 10.7% versus 2.3% [P < 0.001]‚ respectively; year 2, 17.2% versus 4.3% [P < 0.001], respectively) with no difference in other chronic lesions. The death-censored graft failure rate was higher in patients with g > 0 as compared with g = 0 (hazard ratio, 1.68 [95% CI, 1.07-2.65]; P = 0.02). We did not find any difference in outcomes in glomerulitis group based on donor-specific antibody. Conclusion. Our findings suggest that early glomerulitis (seen within 4 mo after transplantation) may lead to clinically significant long-term changes and thus could be a target for early intervention therapies.
David O. Warner, M.D., Recipient of the 2022 Excellence in Research Award
Warner, Mark A.

Mayo Clinic

Anesthesiology | September 22, 2022 | Volume: 137 | Issue: 4 | Pages: 396-398

10.1097/aln.0000000000004362 Get It

Anesthesiologists and the Other Pandemic: Tobacco Use
Warner, David O. , Warner, David O

Mayo Clinic

Anesthesiology | September 22, 2022 | Volume: 137 | Issue: 4 | Pages: 484-508

10.1097/aln.0000000000004346 | PMID 36137257 Get It

Tobacco use will kill a projected 1 billion people in the 21st century in one of the deadliest pandemics in history. Tobacco use disorder is a disease with a natural history, pathophysiology, and effective treatment options. Anesthesiologists can play a unique role in fighting this pandemic, providing both immediate (reduction in perioperative risk) and long-term (reduction in tobacco-related diseases) benefits to their patients who are its victims. Receiving surgery is one of the most powerful stimuli to quit tobacco. Tobacco treatments that combine counseling and pharmacotherapy (e.g., nicotine replacement therapy) can further increase quit rates and reduce risk of morbidity such as pulmonary and wound-related complications. The perioperative setting provides a great opportunity to implement multimodal perianesthesia tobacco treatment, which combines multiple evidence-based tactics to implement the four core components of consistent ascertainment and documentation of tobacco use, advice to quit, access to pharmacotherapy, and referral to counseling resources.
Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
Masuda, Mia Y. , Barshow, Suzanne , Garg, Shipra , Putikova, Arina, LeSuer, William E., Alexander, Jeffrey A. , Katzka, David A. , Dellon, Evan S. , Kita, Hirohito , Horsley‐Silva, Jennifer L. , Doyle, Alfred D. , Wright, Benjamin L. , Kita, H , Wright, Benjamin L

Mayo Clinic

Clinical and Translational Gastroenterology | September 22, 2022 | Volume: 13 | Issue: 11 | Pages: e00534

10.14309/ctg.0000000000000534 | PMID 36137185 Get It

INTRODUCTION: We aimed to assess the diagnostic utility of eosinophil peroxidase (EPX) staining on Cytosponge (CS) samples in eosinophilic esophagitis (EoE). METHODS: Esophageal biopsy (BX) samples from adult subjects with EoE were assessed using peak eosinophils per high-power field (eos/hpf), EPX, and the EoE histologic scoring system. EPX staining and eos/hpf were compared (BX vs CS). RESULTS: CS EPX positivity correlated with eos/hpf (CS [ r = 0.82, P < 0.0001]; BX [ r = 0.65, P < 0.0001]) and EoE histologic scoring system (grade [ r = 0.62, P < 0.00001]; stage [ r = 0.61, P < 0.0001]). CS EPX identified subjects with active EoE (area under the curve = 0.86, P < 0.0001). DISCUSSION: The correlation of CS EPX with eosinophilic inflammation and histologic disease severity supports its diagnostic utility in EoE.
Temporal association between invasive procedures and infective endocarditis
Thornhill, Martin H. , Crum, Annabel , Campbell, Richard , Stone, Tony , Lee, Ellen , Bradburn, Mike , Fibisan, Veronica , Dayer, Mark , Prendergast, Bernard , Lockhart, Peter B. , Nicoll, Jon, Prendergast, Bernard D , Baddour, Larry , Thornhill, M H , Dayer, Mark J , Baddour, Larry M. , Stone, Tony

Mayo Clinic

Heart | September 22, 2022 | Volume: 109 | Issue: 3 | Pages: 223-231

10.1136/heartjnl-2022-321519 | PMID 36137742 Get It

Objective Antibiotic prophylaxis has been recommended for patients at increased risk of infective endocarditis (IE) undergoing specific invasive procedures (IPs) despite a lack of data supporting its use. Therefore, antibiotic prophylaxis recommendations ceased in the mid-2000s for all but those at high IE risk undergoing invasive dental procedures. We aimed to quantify any association between IPs and IE. Methods All 14 731 IE hospital admissions in England between April 2010 and March 2016 were identified from national admissions data, and medical records were searched for IP performed during the 15-month period before IE admission. We compared the incidence of IP during the 3 months immediately before IE admission (case period) with the incidence during the preceding 12 months (control period) to determine whether the odds of developing IE were increased in the 3 months after certain IP. Results The odds of IE were increased following permanent pacemaker and defibrillator implantation (OR 1.54, 95% CI 1.27 to 1.85, p<0.001), extractions/surgical tooth removal (OR 2.14, 95% CI 1.22 to 3.76, p=0.047), upper (OR 1.58, 95% CI 1.34 to 1.85, p<0.001) and lower gastrointestinal endoscopy (OR 1.66, 95% CI 1.35 to 2.04, p<0.001) and bone marrow biopsy (OR 1.76, 95% CI 1.16 to 2.69, p=0.039). Using an alternative analysis, bronchoscopy (OR 1.33, 95% CI 1.06 to 1.68, p=0.049) and blood transfusions/red cell/plasma exchange (OR 1.2, 95% CI 1.07 to 1.35, p=0.012) were also associated with IE. Conclusions This study identifies a significant association between specific IPs (permanent pacemaker and defibrillator implantation, dental extraction, gastrointestinal endoscopy and bronchoscopy) and subsequent IE that warrants re-evaluation of current antibiotic prophylaxis recommendations to prevent IE in high IE risk individuals.
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
García-Carro, Clara , Prosek, Jason, Garcia, Pablo, Abudayyeh, Ala , Lumlertgul, Nuttha , Malik, Abhinav , Loew, Sebastian, Beckerman, Pazit , Renaghan, Amanda DeMauro , Carlos, Christopher A., Rashidi, Arash , Mithani, Zain, Deshpande, Priya , Rangarajan, Sunil , Seigneux, Sophie de , Campedel, Luca , Shin, Daniel Sanghoon , Coppock, Gaia, Ortiz-Melo, David I. , Aggarwal, Vikram , Benesova, Karolina, Wanchoo, Rimda, Murakami, Naoka , Cortazar, Frank B. , Reynolds, Kerry L. , Sise, Meghan E. , Soler, María José , Leaf, David E. , Bermejo, Sheila , Salem, Joe‐Elie , Gupta, Shruti , Kitchlu, Abhijat , Reynolds, Kerry L , Soler, Maria Jose , Leaf, David E , Murakami, Naoka , Salem, Joe-Elie , Koessler, Thibaud , Gupta, Shruti , Glezerman, Ilya G , Herrmann, Sandra M. , Malik, A Bilal, Shah, Chintan V , Kitchlu, Abhijat , Sprangers, Ben

Mayo Clinic

Journal for ImmunoTherapy of Cancer | September 22, 2022 | Volume: 10 | Issue: 9 | Pages: e005646

10.1136/jitc-2022-005646 | PMID 36137651 Get It

Background Corticosteroids are the mainstay of treatment for immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI), but the optimal duration of therapy has not been established. Prolonged use of corticosteroids can cause numerous adverse effects and may decrease progression-free survival among patients treated with ICPis. We sought to determine whether a shorter duration of corticosteroids was equally efficacious and safe as compared with a longer duration. Methods We used data from an international multicenter cohort study of patients diagnosed with ICPi-AKI from 29 centers across nine countries. We examined whether a shorter duration of corticosteroids (28 days or less) was associated with a higher rate of recurrent ICPi-AKI or death within 30 days following completion of corticosteroid treatment as compared with a longer duration (29–84 days). Results Of 165 patients treated with corticosteroids, 56 (34%) received a shorter duration of treatment and 109 (66%) received a longer duration. Patients in the shorter versus longer duration groups were similar with respect to baseline and ICPi-AKI characteristics. Five of 56 patients (8.9%) in the shorter duration group and 12 of 109 (11%) in the longer duration group developed recurrent ICPi-AKI or died (p=0.90). Nadir serum creatinine in the first 14, 28, and 90 days following completion of corticosteroid treatment was similar between groups (p=0.40, p=0.56, and p=0.89, respectively). Conclusion A shorter duration of corticosteroids (28 days or less) may be safe for patients with ICPi-AKI. However, the findings may be susceptible to unmeasured confounding and further research from randomized clinical trials is needed.
Beyond meet: The future of scientific meetings
Brinjikji, Waleed

Mayo Clinic

Interventional Neuroradiology | September 22, 2022 | Volume: 28 | Issue: 5 | Pages: 505-507

10.1177/15910199221125406 | PMID 36136365 Get It